Nintendo Switch added another string to its bow today, with the launch of a new digital comic book app exclusive to the gaming console.
InkyPen is a subscription service offering access to 'thousands' of digital comics, with plans to open up to manga in the near future.
The Norwegian startup is billed as an "all-you-can read comic subscription service for Nintendo Switch", and joins a very selective roster of non-gaming apps on the console – alongside YouTube and Hulu, but still missing the likes of Netflix and Amazon Prime Video.
The Nintendo Switch's 6.2-inch screen wasn't necessarily made with comic-reading in mind, though the InkyPen app allows you to zoom in on successive panels to offset this – and you always have the option of displaying comics on your TV via the Switch dock.
Read comics on Nintendo Switch™ with InkyPen! This subscription-based application is available now on Nintendo eShop. pic.twitter.com/hlmgEJgpMxDecember 17, 2018
An open book
Given the lack of big-name apps like Netflix, or even Comixology – Amazon's own subscription service for digital comic – it's curious that Nintendo would launch a new service on the Switch console, though the Norwegian startup offers most of its content globally.
InkyPen is now available globally on the Nintendo eShop, as of today. You can download the software for free, but will need a $7.99 / €7.99 monthly subscription (around £6.99) to access the service.
By contrast Amazon's larger Comixology service retails at $5.99 – though is still only available in the US.
- New Nintendo Switch: everything we want to see from a new Switch console
Get daily insight, inspiration and deals in your inbox
Get the hottest deals available in your inbox plus news, reviews, opinion, analysis and more from the TechRadar team.
Henry is a freelance technology journalist, and former News & Features Editor for TechRadar, where he specialized in home entertainment gadgets such as TVs, projectors, soundbars, and smart speakers. Other bylines include Edge, T3, iMore, GamesRadar, NBC News, Healthline, and The Times.